scholarly journals Delays in breast cancer care by race and sexual orientation: Results from a national survey with diverse women in the United States

Cancer ◽  
2021 ◽  
Author(s):  
Tonia C. Poteat ◽  
Mary Anne Adams ◽  
Jowanna Malone ◽  
Sophia Geffen ◽  
Naomi Greene ◽  
...  
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Sexual Orientation ◽  
National Survey ◽  
Cancer Care ◽  
The United States ◽  
Breast Cancer Care

scholarly journals Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States

JAMA Oncology ◽  
2017 ◽  
Vol 3 (7) ◽  
pp. 928 ◽  
Author(s):  
Bobby Daly ◽  
Olufunmilayo I. Olopade ◽  
Ningqi Hou ◽  
Katharine Yao ◽  
David J. Winchester ◽  
...  
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Endocrine Therapy ◽  
Cancer Care ◽  
The United States ◽  
Adjuvant Endocrine Therapy ◽  
Breast Cancer Care ◽  
Therapy Delivery

scholarly journals Breast cancer care in the Canada and the United States: Ecological comparisons of extremely impoverished and affluent urban neighborhoods

2010 ◽  
Vol 16 (1) ◽  
pp. 156-163 ◽  
Author(s):  
Kevin M. Gorey ◽  
Isaac N. Luginaah ◽  
Caroline Hamm ◽  
Karen Y. Fung ◽  
Eric J. Holowaty
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Cancer Care ◽  
The United States ◽  
Urban Neighborhoods ◽  
Breast Cancer Care

Breast Cancer Care: Developments in 1998

1998 ◽  
Vol 5 (4) ◽  
pp. 338-345
Author(s):  
John Horton
Keyword(s):  
Breast Cancer ◽  
Cancer Care ◽  
Metastatic Breast ◽  
The United States ◽  
Axillary Node ◽  
Standards Of Care ◽  
Sources Of Information ◽  
Breast Cancer Care ◽  
Mortality And Morbidity ◽  
American Society

Background Breast cancer is a significant cause of mortality and morbidity worldwide, although death rates in the United States and some other countries are beginning to fall. Methods Several sources of information in 1998, including publications and presentations at the 1998 meeting of the American Society of Clinical Oncology, are pertinent to contemporary breast cancer care. Results It is now possible to prescribe hormonal therapy that will reduce the incidence of breast cancer. Methods are available to reduce the morbidity from axillary node dissection, and improvements in adjuvant therapy and management of metastatic breast cancer are now at hand. Conclusions The information presented provides a broad-based platform for new standards of care for breast cancer that will serve as a sound base for further progress in this important disease.

What Are the Ethical Implications of Understanding and Treating Breast Cancer?

2018 ◽  
Author(s):  
Mary Ann G. Cutter
Keyword(s):  
Breast Cancer ◽  
Risk Assessment ◽  
Informed Consent ◽  
Cancer Care ◽  
The United States ◽  
Breast Cancer Patients ◽  
Breast Cancer Care ◽  
Ethical Implications ◽  
Personalized Approach ◽  
Limit Access

Philosophically speaking, the question “What are the ethical implications of understanding breast cancer?” raises a host of issues, including informed consent, risk assessment, and access to breast cancer care. What we find is that, initially, there are adequate guidelines for informed consent, adequate efforts to develop risk assessment measures, and a decent level of access to breast cancer care in the United States. But things can be improved from an ethical standpoint. Upon reflection, the informed consent process would benefit from a more explicit discussion of uncertainty in breast cancer medicine and the ways breast cancer patients make decisions about their care. Risk assessments would benefit from a more personalized approach. Access to breast cancer care could be improved by continued studies of the diverse forces that limit access to proper breast cancer care.

scholarly journals Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: a Senonetwork National Survey

2020 ◽  
Author(s):  
Lucio Fortunato ◽  
Giulia d’Amati ◽  
Mario Taffurelli ◽  
Corrado Tinterri ◽  
Lorenza Marotti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
National Survey ◽  
Cancer Care ◽  
Breast Cancer Care

scholarly journals Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: Greater socioeconomic inequity in America

2009 ◽  
Vol 32 (3) ◽  
pp. 239 ◽  
Author(s):  
Kevin M Gorey ◽  
Isaac N Luginaah ◽  
Eric J Holowaty ◽  
Karen Y Fung ◽  
Caroline Hamm
Keyword(s):  
Breast Cancer ◽  
Socioeconomic Status ◽  
Low Income ◽  
Cancer Care ◽  
Radiation Treatment ◽  
The United States ◽  
Historical Study ◽  
Adjuvant Radiation ◽  
Breast Cancer Care ◽  
Socioeconomic Inequity

Purpose. The demand for cancer care has increased among aging North American populations as cancer treatment innovations have proliferated. Gaps between supply and demand may be growing. This study examined whether socioeconomic status has a differential effect on waits for surgical and adjuvant radiation treatment (RT) of breast cancer in Canada and the US. Methods. Ontario and California cancer registries provided 929 and 984 breast cancer cases diagnosed between 1998 and 2000 in diverse urban and rural places. Residence-based socioeconomic data were taken from censuses. Cancer care variables were reliably abstracted from health records: stage, receipt of surgery and RT, and waits from diagnosis to initial and initial to adjuvant treatment. Median waits were compared within- and between-country with the non-parametric Mann-Whitney U-test. Categorically long, age-adjusted wait comparisons used the Mantel-Haenszel chi-square test. Results. There were significant associations between lower socioeconomic status and longer surgical waits, lower access to adjuvant RT and to longer RT waits across diverse places in California. None were observed in Ontario. The two cohorts did not practically differ on access to surgery or on surgical waits. Compared with their counterparts in California, low-income Ontarians, particularly those in small urban places, gained greater access to RT, while high-income Americans had shorter waits for RT. Conclusions. This historical study contextualized Canada’s “waiting-list problems” with evidence on breast cancer care, where lower income Americans seemed to have waited as long as similar Canadians. Many more low-income Americans seemed to experience the longest wait of all for adjuvant care. They simply did not receive it. In contrast to stark American socioeconomic inequity, this study evidenced remarkable equity in Canadian breast cancer care.

Effect of shorter time to treatment on survival in rural patients with breast cancer.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 7027-7027
Author(s):  
Suneel Deepak Kamath ◽  
Wei Wei ◽  
Katherine Tullio ◽  
Gregory S. Cooper ◽  
Alok A. Khorana
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Socioeconomic Factors ◽  
Cancer Care ◽  
The United States ◽  
Disease Stage ◽  
Cancer Center ◽  
Median Income ◽  
Cox Models ◽  
Rural Patients

7027 Background: Rural cancer care in the United States has unique challenges from variable access to care. This study examined differences in time to first treatment (TTT), a potential surrogate for access, and predictors of overall survival (OS) between rural and non-rural patients with breast cancer. Methods: Women with stage I-III breast cancer from 2004-2012 in the National Cancer Database of Commission on Cancer (CoC)-accredited facilities were included and categorized as rural and non-rural. Differences in demographic, disease and treatment characteristics, socioeconomic factors and TTT (< 4 weeks, 4-8 weeks and > 8 weeks) between rural and non-rural patients were assessed by Chi-square test. The effect of age, insurance status, cancer center type, community median income, community % no high school, and TTT on OS were assessed using univariate and multivariate Cox models. Results: The study included 1,205,031 patients, 18,417 (2%) of whom were rural. Compared to non-rural patients, rural patients were more likely to be age > 65, Caucasian, receive care at non-academic centers, have government insurance, have lower income and less education (p < 0.0001 for all). Significant demographic and socioeconomic differences are shown in Table. Rural patients had shorter mean TTT (3.72 vs. 4.35 weeks, p < 0.0001). More rural patients had TTT < 4 weeks (67% vs. 57%) and < 8 weeks (94% vs. 90%), p < 0.0001 for both. Shorter TTT (both < 4 weeks vs. 8 weeks and 4-8 weeks vs. > 8 weeks) was associated with improved OS (HR: 0.84, 95% CI: 0.82-0.86, p < 0.0001 and HR: 0.82, 95% CI: 0.81-0.83, p < 0.0001, respectively). After adjusting for demographic, socioeconomic, disease stage and treatment factors, rural status was associated with significantly better OS compared to non-rural status (HR: 0.92, 95% CI: 0.89-0.96, p < 0.0001). Conclusions: Despite several adverse socioeconomic factors, rural patients with breast cancer with access to CoC-accredited facilities had significantly shorter TTT and better OS compared to non-rural patients. These data suggest improving TTT can mitigate disparities in rural cancer care. It is unclear whether our data apply to non-CoC-accredited facilities in rural United States. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document